{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:26:51Z","timestamp":1785464811498,"version":"3.56.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Bilastine is a non-sedating second generation H1 oral antihistamine (OAH) for treating allergic rhinitis (AR) patients. The effect of bilastine has not previously been evaluated in a meta-analysis. The aim of this review was to determine the efficacy and safety of bilastine in treating AR. An electronic literature search was performed using Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Science Direct and Google Scholar up to March 2021. Randomized controlled trials comparing bilastine with placebo and standard pharmacotherapy were included. The included studies must have diagnosis of AR established by clinicians and the outcomes must have a minimum of 2\u00a0weeks of follow-up period. The primary outcomes assessed were total symptom score (TSS), nasal symptom score (NSS) and non-nasal symptom score (NNSS). The secondary outcomes were discomfort due to rhinitis, quality of life (QOL) and adverse events. The risk of bias and quality of evidence for all studies were appraised. The meta-analysis was done using Review Manager 5.3 software based on the random-effects model. The search identified 135 records after removal of duplicates. Following screening and review of the records, fifteen full-text articles were assessed for eligibility. Five trials involving 3,329 patients met the inclusion criteria. Bilastine was superior to placebo in improving TSS, NSS, NNSS, rhinitis discomfort score and QOL but has comparable efficacy with other OAHs in TSS, NSS, NNS, rhinitis discomfort score and QOL. There was no difference in adverse effects when bilastine was compared against placebo and other OAHs except for somnolence. Bilastine has fewer incidence of somnolence compared to cetirizine. The overall quality of evidence ranged from moderate to high quality. Bilastine is effective and safe in treating the overall symptoms of AR with comparable efficacy and safety with other OAHs except somnolence. Whilst bilastine has similar efficacy to cetirizine, somnolence is notably less in bilastine.<\/jats:p>","DOI":"10.3389\/fphar.2021.731201","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T06:05:51Z","timestamp":1641794751000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Aranjit","family":"Singh Randhawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norhayati","family":"Mohd Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Khairi","family":"Md Daud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baharudin","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1398-9995.2008.01813.x","article-title":"Comparison of the Efficacy and Safety of Bilastine 20 Mg vs Desloratadine 5 Mg in Seasonal Allergic Rhinitis Patients","volume":"64","author":"Bachert","year":"2009","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1185\/03007995.2011.648263","article-title":"Establishing the Place in Therapy of Bilastine in the Treatment of Allergic Rhinitis According to ARIA: Evidence Review","volume":"28","author":"Bousquet","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (In Collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11882-014-0422-z","article-title":"New Therapies for Allergic Rhinitis","volume":"14","author":"Braido","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1398-9995.2009.02089.x","article-title":"GA(2)LEN Skin Test Study II: Clinical Relevance of Inhalant Allergen Sensitizations in Europe","volume":"64","author":"Burbach","year":"2009","journal-title":"Allergy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/0019-5154.110832","article-title":"Pharmacology of Antihistamines","volume":"58","author":"Church","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"ED000142","DOI":"10.1002\/14651858.ED000142","article-title":"Updated Guidance for Trusted Systematic Reviews: a New Edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.26355\/eurrev_201802_14318","article-title":"Bilastine Safety in Drivers Who Need Antihistamines: New Evidence from High-Speed Simulator Driving Test on Allergic Patients","volume":"22","author":"Demonte","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cQuality of Evidence\u201d and Why is it Important to Clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00011-009-0117-4","article-title":"The Effects of Bilastine Compared with Cetirizine, Fexofenadine, and Placebo on Allergen-Induced Nasal and Ocular Symptoms in Patients Exposed to Aeroallergen in the Vienna Challenge Chamber","volume":"59","author":"Horak","year":"2010","journal-title":"Inflamm. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2500\/ajra.2014.28.4049","article-title":"Bilastine as a Potential Treatment in Allergic Rhinitis","volume":"28","author":"Kowal","year":"2014","journal-title":"Am. J. Rhinol Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0030-6657(09)70180-5","article-title":"Leki Przeciwhistaminowe W Leczeniu Alergicznego Nie\u017cytu Nosa - Uaktualnienie 2008\/2009","volume":"63","author":"Kruszewski","year":"2009","journal-title":"Otolaryngologia polska"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/j.1365-2222.2009.03257.x","article-title":"Efficacy and Safety of Bilastine 20 Mg Compared with Cetirizine 10 Mg and Placebo for the Symptomatic Treatment of Seasonal Allergic Rhinitis: a Randomized, Double-Blind, Parallel-Group Study","volume":"39","author":"Kuna","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.36849\/JDD.2020.4835","article-title":"Multidisciplinary Real-World Experience with Bilastine, a Second Generation Antihistamine","volume":"19","author":"Lynde","year":"2020","journal-title":"J. Drugs Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/pai.12555","article-title":"Safety and Tolerability of Bilastine 10 Mg Administered for 12 Weeks in Children with Allergic Diseases","volume":"27","author":"Nov\u00e1k","year":"2016","journal-title":"Pediatr. Allergy Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.alit.2016.05.014","article-title":"Efficacy and Safety of Bilastine in Japanese Patients with Perennial Allergic Rhinitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Study","volume":"66","author":"Okubo","year":"2017","journal-title":"Allergol. Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biopha.2017.06.008","article-title":"Second Generation H1 - Antihistamines Interaction with Food and Alcohol-A Systematic Review","volume":"93","author":"Pa\u015bko","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/14740338.2018.1502268","article-title":"Comparative Study of the Effect of Bilastine and Cetirizine on Cognitive Functions at Ground Level and at an Altitude of 4,000 M Simulated in Hypobaric Chamber: a Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study","volume":"17","author":"Rem\u00e9nyi","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12948-015-0008-x","article-title":"Bilastine: New Insight into Antihistamine Treatment","volume":"13","author":"Ridolo","year":"2015","journal-title":"Clin. Mol. Allergy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1185\/03007995.2011.640667","article-title":"Efficacy and Safety of Bilastine 20 Mg Compared with Cetirizine 10 Mg and Placebo in the Treatment of Perennial Allergic Rhinitis","volume":"28","author":"Sastre","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"B22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40265-016-0682-0","article-title":"Sedative Effects of Levocetirizine: A Systematic Review and Meta-Analysis of Randomized Controlled Studies","volume":"77","author":"Snidvongs","year":"2017","journal-title":"Drugs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3357\/AMHP.4522.2016","article-title":"Cognitive Performance Effects of Bilastine 20 Mg during 6 hours at 8000 Ft Cabin Altitude","volume":"87","author":"Valk","year":"2016","journal-title":"Aerosp Med. Hum. Perform."},{"key":"B24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2147\/TCRM.S105189","article-title":"Treatment of Allergic Rhinitis and Urticaria: a Review of the Newest Antihistamine Drug Bilastine","volume":"12","author":"Wang","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"B25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.anai.2011.10.018","article-title":"Cost, Utilization, and Patterns of Medication Use Associated with Chronic Idiopathic Urticaria","volume":"108","author":"Zazzali","year":"2012","journal-title":"Ann. Allergy Asthma Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.731201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T06:06:02Z","timestamp":1641794762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.731201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":25,"alternative-id":["10.3389\/fphar.2021.731201"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.731201","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"article-number":"731201"}}